For Now, with Current Terminology, Cost- Driven ‡ BASED ON FAMILY HX (GENES) AGE, ?KETOSIS PRONE BMI, ANTIBODIES If cost ‘less of an Issue’- antibodies.

Slides:

Advertisements

Similar presentations

Age-Adjusted Prevalence of Diagnosed Diabetes Among U.S. Adults

Advertisements

CF Related Diabetes ADEU November Cystic Fibrosis Genetic disorder Exocrine pancreas dysfunction Autosomal recessive inheritance Several identified.

Pathophysiology of Type 1 Diabetes

1 Diagnosis of Type 1 Diabetes. 2 Classifying Diabetes IAA, autoantibodies to insulin; GADA, glutamic acid decarboxylase; IA-2A, the tyrosine phosphatase.

Type 1? Type 2? LADA? A Diagnostic Challenge David Winmill, DNP, CDE, BC-ADM Diabetes Update 2010.

Groupe de recherche PRIMUS. Time to Insulin Initiation in Diabetic Patients: A Quebec Population-Based Analysis Present by: Shabnam Asghari M.D. Ph.D.

1 Background Hypertension Type 2 diabetes Coronary heart disease Gallbladder disease Certain cancers Dyslipidemia Stroke Osteoarthritis Sleep apnea Approximately.

Type 2 diabetes By the numbers. Prevalence of Diagnosed and Undiagnosed Diabetes in the United States, All Ages, 2007 Total: 23.6 million people—7.8 percent.

County-Level Ranks Diagnosed Diabetes Prevalence

County-Level Estimates of Diagnosed Diabetes Incidence Among Adults Aged ≥ 20 Years Trends 2004 – 2009.

Diasoce2.ppt1 Symptoms of diabetes mellitus Basic –Thirst –Polyuria –Weight loss –Fatigue Other –Muscle cramps –Obstipation –Blurred vision –Fungal and.

Diagnosis of Type 1 Diabetes

Genes, Environment- Lifestyle, and Common Diseases Chapter 5.

Obesity Projects: Lessons Learned and Relearned Daniel E. Hale, M.D Professor of Pediatrics, UTHSCSA.

Note No cow’s milk or cow’s milk products (including but not limited to cheese and yoghurt) under the age of one year -casein (a protein in cow’s milk)

Geography Population Population Pyramids[Date] Today I will: -Know how to draw and begin to interpret a population pyramid.

Is it type 2 or type 1 diabetes? Practice nurse F Kavanagh DSNs: F Spear, J Guest, B Wright GPs: Dr N Cowap, Dr M Khalid Consultants: Dr S George, Dr P.

CDC’s Division of Diabetes Translation. National Diabetes Surveillance System available at Obesity (BMI≥30 kg/m.

IDC 1.1 Global and National Burden of Diabetes Diabetes Mellitus: classification New (WHO) Screening and Diagnostic Criteria –Diabetes, Impaired Glucose.

The University of Georgia Cooperative Extension Definition Group of diseases marked by high blood glucose (blood sugar) levels Caused by defects in Insulin.

1 Genes, Environment- Lifestyle, and Common Diseases Chapter 5.

Genes, Environment, and Common Diseases Chapter 5 Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.

Diagnosing Diabetes In Adults– Type 1, LADA, or Type 2? Stanley Schwartz MD, FACE, FACP Affiliate Main Line Health Emeritus, Clinical Assoc. Prof. of Medicine.

Genetics and genomics for healthcare © 2014 NHS National Genetics and Genomics Education Centre Genetics and Genomics: Alert,

Diagnosing Diabetes In Adults– Type 1, LADA, or Type 2?

Plasma lipid fractions in different HMGCR SNP genotypes Mean difference in plasma lipid fraction concentration(mmol/L) rs SNP genotype (T-control.

Differences between Genders And Age groups. Hypothesis: Male students believe they perform better in traditional classes over online classes while female.

Diagnosing Diabetes In Adults– Type 1, LADA, or Type 2? Stanley Schwartz MD, FACE, FACP Affiliate Main Line Health Emeritus, Clinical Assoc. Prof. of Medicine.

Epidemiology of Diabetes in Hispanic Americans. Prevalence of Abnormal Glucose Tolerance in Three Ethnic Groups.

Role of CTLA-4 polymorphism in susceptibility to type 1 diabetes: Results of a family and a case-control study in Southern Tunisia Immunology Department,

Surge in Newly Identified Diabetes Among Medicaid Patients in 2014 Within Medicaid Expansion States Under the Affordable Care Act Featured Article: Harvey.

Does your patient have T1, T2 or MODY?

Investigation of the Negative Association between Hypertension and Age- Associated Peripheral Neuropathy Dong Yung Cho, MD, James W. Mold, MD, Michelle.

Current Classification of DM Update on Diabetes Classification Celeste C. Thomas, MD, MSa,*, Louis H. Philipson, MD, PhD,Med Clin N Am 99 (2015) 1–16.

Diagnosing Diabetes In Adults– Type 1, LADA, or Type 2? Stanley Schwartz MD, FACE, FACP Affiliate Main Line Health Emeritus, Clinical Assoc. Prof. of Medicine.

CDC’s Division of Diabetes Translation. United States Diabetes Surveillance System available at Obesity (BMI≥30 kg/m 2.

Diagnosing Diabetes Mellitus in Adults: Type 1, LADA, Type 2 Stanley Schwartz MD, FACE, FACP Affiliate, Main Line Health System Emeritus, Clinical Assoc.

(*BMI ≥30, or ~ 30 lbs. overweight for 5’ 4” person) No Data

Efficacy of Immunotherapy in T1DM: Some Can Delay Decline in C-peptide

Genetics of Type 1 Diabetes

Diabetes and Gestational Diabetes Trends Among Adults in the U. S

Multiple Alleles Human Blood Types.

A Clinical-Translator’s Point-of-View:

EU funding opportunities

Targets for Therapies/ New Guidelines

Diagnosis of Type 1 Diabetes

A Unifying Pathophysiologic Approach to The Complications of Diabetes in the Context of the Beta-cell Classification of Diabetes: A Framework for Understanding.

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Bimodal distribution of the glutamic acid decarboxylase

John A Todd, Linda S Wicker Immunity

Anthony J. Bleyer, Stanislav Kmoch Kidney International

Obesity Trends* Among U.S. Adults BRFSS, 1990, 2000, 2010

by Agata Juszczak, Rebecca Pryse, Andrew Schuman, and Katharine R Owen

Nat. Rev. Endocrinol. doi: /nrendo

(A) ChIP-qPCR to verify the recruitment of ISWI to the UAS sites

Obesity Trends* Among U.S. Adults BRFSS, 1990, 1999, 2009

Is it type 2 or type 1 diabetes?

Inclusion process. Inclusion process. Of 5200 eligible patients, 204 declined participation, 111 had diabetes >400 days before All New Diabetics in Scania.

Baseline characteristics of older women (NHS I), younger women (NHS II), and men (HPFS) with a history of hypertension according to thiazide use Eric N.

Jeffrey B. Geske et al. JCHF 2018;j.jchf

New diabetes stratification

The development of plasma (p-)C-peptide responses to an intravenous glucose (0.5 g glucose/kg body wt) and glucagon (1 mg) infusion test up to 5–7 years.

This pooled data from 11 prospective cohort studies with 650,386 white adults found a significant correlation in all-cause mortality when waist circumference.

Targeted disruption of the mouse Atp1a2.

Multipoint quantitative linkage analysis of BMI in Campora.

Trajectories over the 9 years of follow-up of HbA1c in all participants (n = 4,080 at baseline), stratified by the presence of a family history of diabetes,

Partial pedigrees for novel INS mutations identified in probands with MODY and young type 2 diabetes. Partial pedigrees for novel INS mutations identified.

Adjusted ORs for pregravid, antepartum, and postpartum factors as predictors of likelihood that a woman will gain weight between 3 and 12 months postpartum.

Risk of type 2 diabetes as a function of ABCA1 and ABCG1 genotype in CCHS. Hazard ratios were multifactorially adjusted for age, sex, BMI, hypertension,

Schematic depiction of three stages of the natural history of T2D, noting several opportunities for improvement of management. Schematic depiction of three.

Presentation transcript:

For Now, with Current Terminology, Cost- Driven ‡ BASED ON FAMILY HX (GENES) AGE, ?KETOSIS PRONE BMI, ANTIBODIES If cost ‘less of an Issue’- antibodies in all Stanford Antibody Chip- fraction of cost of RAI At some point,NOW- genotype all FH + (-) Ketosis prone Younger BMI >30 Type 2 Older (-) Ketosis prone FH+ BMI >30 Type 2 Genome to Clarify <30 BMI MODY ‘LADA’ SPIDDM Autoimmune Type2 BMI <30 Antibody /HLA to Verify FH - ( +) ketosis prone Younger Type 1 ‘LADA’ SPIDDM Autoimmune Type2 Antibody /HLA to Verify BMI >30 Diagnosis of Diabetes in Adults ‡

So For Now, with Current Terminology, Cost- Driven Diagnosis of Diabetes in Adults ‡ FH + (-) Ketosis prone Younger BMI >30 Type 2 Older (-) Ketosis prone FH+ BMI >30 Type 2 Genome to Clarify <30 BMI MODY ‘LADA’ SPIDDM Autoimmune Type2 BMI <30 Antibody /HLA to Verify ‡ BASED ON FAMILY HX (GENES) AGE, ?KETOSIS PRONE BMI, ANTIBODIES If cost ‘less of an Issue’- antibodies in all Stanford Antibody Chip- fraction of cost of RAI At some point, NOW-genotype all

So For Now, with Current Terminology, Cost- Driven FH - ( +) ketosis prone Younger Type 1 ‘LADA’ SPIDDM Autoimmune Type2 Antibody /HLA to Verify BMI >30 Diagnosis of Diabetes in Adults ‡ ‡ BASED ON FAMILY HX (GENES) AGE, ?KETOSIS PRONE BMI, ANTIBODIES If cost ‘less of an Issue’- antibodies in all Stanford Antibody Chip- fraction of cost of RAI At some point, NOW- genotype all

So For Now, with Current Terminology, Cost- Driven FH + (-) Ketosis prone Younger BMI >30 Type 2 Older (-) Ketosis prone FH+ BMI >30 Type 2 Genome to Clarify <30 BMI MODY ‘LADA’ SPIDDM Autoimmune Type2 BMI <30 Antibody /HLA to Verify FH - ( +) ketosis prone Younger Type 1 ‘LADA’ SPIDDM Autoimmune Type2 Antibody /HLA to Verify BMI >30 Diagnosis of Diabetes in Adults ‡ ‡ BASED ON FAMILY HX (GENES) AGE, ?KETOSIS PRONE BMI, ANTIBODIES If cost ‘less of an Issue’- antibodies in all Stanford Antibody Chip- fraction of cost of RAI At some point, NOW- genotype all VOILA et MERCI